Over the last 10 years DDW has firmly established itself as a highly respected and the 'must read' journal within the drug discovery & development arena. DDW is renown for voicing the opinions of some of the Industry's leading luminaries and has become a recognised platform for 'Industry Gurus' to talk about and encourage debate on some of the more challenging issues surrounding the technological and business facets of the biopharmaceutical industry. DDW adheres to the maxim ......'Turning Science into Business'

DDW examines the advances in new science and technology with a view to the commercial implications of implementing those advances and whether they can truly bring benefits to the industry as a whole and, more importantly, the discovery and development of new therapeutics.

DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level allowing them to understand the new technologies and the impact they can have on their particular segments of the business. Scientist and CEO alike can profit from the uncomplicated style of the editorial and, furthermore, gain a wealth of information on a diverse range of life science topics. In our articles, we challenge the industry to look at new ways of overcoming discovery bottlenecks, embrace new technologies and build next generation technology platforms.

DDW aims to help the industry survive the 'revolution' as a 'must read' for all those involved in this dynamic sector where time is of the essence and knowledge is power.